多替阿巴拉米片怎么吃

(Simeika) was initially approved for marketing in the United States in 2014 and is currently the only three-in-one compound drug containing dolutegravir (DTG). Dolutegra abalamib tablets (Suimeike) have been approved for marketing in 50 countries and regions, and are recommended by many authoritative academic institutions and authoritative guidelines in Europe and the United States as the first-line first-line treatment for patients with HIV infection.

How to take Dote Abalami Tablets?

For adults and adolescents (weighing at least 40 kg), the recommended dose of Docetaxel is one tablet, once daily.

Adults or adolescents whose body weight is less than 40 kg should not be given Trimax because dolutea (Trimax) is a fixed-dose tablet and cannot be reduced. Dolutegravir, abacavir, or lamivudine is a fixed-dose tablet and should not be used in patients who require dose adjustments. If one of the active ingredients needs to be discontinued or a dose adjustment is required, separate formulations of dolutegravir, abacavir, or lamivudine may be used. In these cases, physicians should refer to the respective product information for these medicines.

If the patient misses a dose of Doptabalamid Tablets (Suimeike), and there are more than 4 hours before the next dose, he should take Doptabalamid Tablets (Suimeike) as soon as possible. If the next dose is less than 4 hours away, patients should not take the missed dose and simply resume their usual dosing schedule.

For pregnant and lactating women, animal data and clinical experience in pregnant women should be considered when deciding to use antiretroviral drugs to treat HIV infection in pregnant women to reduce the risk of vertical transmission of HIV to the newborn. There are no data on the use of Domitabalamid in pregnant women. Data on the use of dolutegravir in pregnant women are limited or non-existent. The effects of dolutegravir on human pregnancy are unknown. Therefore, caution needs to be exercised when actually using doptabalamid tablets (Suimeike) for treatment.

The above is the introduction about (Sui Mei Kai). If patients have other questions about the drug (such as drug price, purchasing channels, etc.), they can consult the medical companion travel service.

Recommended related hot articles: /newsDetail/85393.html